Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)

National Institutes of Health · PAR-25-296 · Deadline: October 19, 2027 · Advertised ceiling: $650k

Opportunity-exact history — these numbers describe this specific funding opportunity (PAR-25-296), from NIH RePORTER.

Awards under this opportunity 1

to 1 distinct organizations. By FY: 2026: 1

Actual award size $3.4M median

range $3.4M – $3.4M

Listing summary

The CTSA Collaborative and Innovative Acceleration Award (CCIA) aims to accelerate the pace of translational research by supporting the collaborative development, dissemination, and sustainable implementation of innovative solutions across the CTSA Program Consortium and beyond. This Notice of Funding Opportunity (NOFO) invites investigator-initiated applications to develop, demonstrate, and disseminate innovative new approaches, technologies, resources, or models that increase the impact of research across diseases, transform the field of translational science, and bring more treatments for a…

Eligibility: Public and State institutions of higher education · Categories: Health, Income Security and Social Services · official listing ↗

This is the free preview

The full brief adds winner tables, recipient breakdowns, the printable "prepared for your client" version, and CSV export — plus a matched-grants list for your client's profile. Client Packet $79 or Pro subscription →

Sources: NIH RePORTER (opportunity-exact) and USAspending (program-level), labeled per section. GrantsDue computes summaries only; verify anything critical against the originals. Methodology.